Detalhe da pesquisa
1.
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
Mult Scler
; 30(2): 261-265, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166437
2.
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Mult Scler
; : 13524585231223880, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357870
3.
The radiologically isolated syndrome: revised diagnostic criteria.
Brain
; 146(8): 3431-3443, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864688
4.
Time to steroids impacts visual outcome of optic neuritis in MOGAD.
J Neurol Neurosurg Psychiatry
; 94(4): 309-313, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600666
5.
Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease.
Mult Scler
; 29(2): 270-276, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453174
6.
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study.
Mult Scler
; 29(9): 1099-1106, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322880
7.
Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society.
Mult Scler
; 29(1): 11-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317497
8.
Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society.
Mult Scler
; 29(1): 37-51, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36345839
9.
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study.
J Neuroinflammation
; 19(1): 62, 2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236386
10.
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Ann Neurol
; 89(1): 30-41, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32959427
11.
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
Mult Scler
; 27(10): 1556-1563, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33124504
12.
The long-term outcome of MOGAD: An observational national cohort study of 61 patients.
Eur J Neurol
; 28(5): 1659-1664, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528851
13.
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
J Neuroinflammation
; 17(1): 128, 2020 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32326965
14.
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.
Mult Scler
; 26(8): 936-944, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31148523
15.
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.
J Neuroinflammation
; 16(1): 134, 2019 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266527
16.
De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine.
Mult Scler
; 25(4): 618-621, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30375922
17.
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Mult Scler
; 22(9): 1231-4, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869528
18.
Impact of executive dysfunction on naming ability in multiple sclerosis.
Rev Neurol (Paris)
; 175(9): 552-559, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221416
19.
[TNF inhibitors and myelitis: think about it, even lately]. / Myélite sous anti-TNFα : y penser, même tardivement.
Therapie
; 69(5): 473-7, 2014.
Artigo
em Francês
| MEDLINE | ID: mdl-25269140
20.
Dental Adverse Effects of Anti-CD20 Therapies.
Neurol Ther
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668835